| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
| 06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
| 06/11/1992 | CA2073564A1 Method for preparing a protein comprising at least one intramolecular disulphide bond by oxidation, at a ph of less than 5.0, of the reduced recombinant protein |
| 06/10/1992 | EP0489711A2 Method for producing human growth hormone |
| 06/10/1992 | EP0489445A2 Method and apparatus for fractionation |
| 06/10/1992 | EP0489058A1 Cystic fibrosis gene |
| 06/10/1992 | CN1016967B Process for purifying human physiologically active polypeptide |
| 06/09/1992 | US5120413 Analysis of samples utilzing capillary electrophoresis |
| 06/09/1992 | CA1303294C .alpha.-HYDROXY THIOETHERS |
| 06/09/1992 | CA1303292C Anhydrous enhanced coupling |
| 06/09/1992 | CA1303131C Conductance measurements in organic solvent |
| 06/09/1992 | CA1303030C Glycosyl derivatives and use thereof |
| 06/09/1992 | CA1303009C Substrates with sterically-protected, stable, covalently-bonded organo-silane films |
| 06/09/1992 | CA1302929C Purification process of tpa |
| 06/08/1992 | WO1992010572A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/08/1992 | CA2097509A1 Native type ii gap, methods for purifying various gaps and uses of gaps to diagnose cancer |
| 06/07/1992 | WO1992010092A1 Very large scale immobilized polymer synthesis |
| 06/07/1992 | CA2097708A1 Very large scale immobilized polymer synthesis |
| 06/07/1992 | CA2057090A1 Method and apparatus for fractionation |
| 06/06/1992 | WO1992010516A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
| 06/06/1992 | CA2095725A1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics and a process for preparing them |
| 06/03/1992 | EP0488622A2 Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/03/1992 | EP0488589A1 Process for producing kappa-casein glycomacropeptides |
| 06/03/1992 | EP0488279A2 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 06/03/1992 | EP0488196A2 HST-2, a member of the heparin binding growth factor family |
| 06/03/1992 | EP0488170A1 Cell-free receptor binding tests, their production and use |
| 06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
| 06/03/1992 | EP0487617A1 Synthetic peptides that enhance cell binding. |
| 06/03/1992 | EP0474789A4 Cysteine thiol-protected peptides for use in immunoassays |
| 06/02/1992 | US5118794 Process for stabilizing human albumin solutions and the solution obtained |
| 06/02/1992 | US5118790 Analogs of hirudin |
| 06/02/1992 | US5118789 Obtained from larvae injured in body wall |
| 06/02/1992 | US5118609 Carrier fleece for use as a reagent carrier from which reagents can be dissolved in immunological analysis |
| 06/02/1992 | CA1302652C Method for purifying granulocyte-macrophage colony stimulating factor |
| 06/02/1992 | CA1302651C Fsh-releasing peptide |
| 06/02/1992 | CA1302648C PROCESS FOR THE PRODUCTION OF N-FORMYL-.alpha.-L-ASPARTYL-L- PHENYLALANINE METHYL ESTER |
| 05/31/1992 | WO1992009620A1 Solution phase process for synthesis of peptide |
| 05/31/1992 | CA2097305A1 Solution phase process for synthesis of peptide |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/31/1992 | CA2056564A1 Somatotropins with alterations in the alpha-helix 3 region, alpha-helix 2 region combinations thereof, and in combination with other mutations |
| 05/30/1992 | WO1992009630A1 Imidoester cross-linked hemoglobin compositions |
| 05/30/1992 | CA2093650A1 Imidoester cross-linked hemoglobin compositions |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/27/1992 | EP0487410A2 Endothelin antagonists |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0487091A2 Optical isomer separating agents |
| 05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486584A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 05/27/1992 | DE4037530A1 Sepn. of microorganism exo-cellular protein, esp. for enzyme - by addn. of adsorbent to remove substances hindering protein pptn., concn., and pptn. of protein |
| 05/27/1992 | DE4037196A1 Verfahren zur reaktivierung von denaturiertem protein A process for the reactivation of denatured protein |
| 05/26/1992 | US5117009 Xanthenylamide handle for use in peptide synthesis |
| 05/26/1992 | US5116962 Material for affinity chromatography which is a sulfated polysaccharide bonded to an insoluble polymer |
| 05/26/1992 | US5116952 Protein active in humoral hypercalcemia of malignancy-pthrp |
| 05/26/1992 | US5116951 Substantially pure interleukin-9 receptor and uses thereof |
| 05/26/1992 | US5116947 Process for the preparation of retro-inverso peptides and new intermediates thereof |
| 05/26/1992 | US5116942 Protein having an inflammatory phospholipase a2 inhibitory activity |
| 05/26/1992 | US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof |
| 05/26/1992 | US5116816 Immunosuppressants, antiinflammatory, parasiticides |
| 05/26/1992 | US5116755 Asexual blood stage antigens of plasmodium falciparum which encode a rhoptry protein |
| 05/26/1992 | US5116726 Methods for removal of detergents from analytes |
| 05/26/1992 | US5116513 Polyaspartic acid as a calcium sulfate and a barium sulfate inhibitor |
| 05/26/1992 | CA1302005C Aminoacid derivatives as antihypertensives |
| 05/26/1992 | CA1301680C Process of preparing physiologically active proteinaceous solutions |
| 05/23/1992 | WO1992009622A1 Process for reactivating denatured protein |
| 05/22/1992 | CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them |
| 05/22/1992 | CA2055869A1 Optical isomer separating agents |
| 05/21/1992 | CA2055813A1 Cyclosporin immunoassay |
| 05/20/1992 | WO1992008689A1 Protein staining compositions and methods |
| 05/20/1992 | EP0486214A2 Putrescine N-methyltransferase, recombinant DNA molecules encoding putrescine N-methyltrasferase, and transgenic tobacco plants with altered nicotine content |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485510A1 High gel strength and low electroendosmosis agarose |
| 05/20/1992 | EP0485458A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same. |
| 05/20/1992 | EP0485380A1 Immunological use of microwaves |
| 05/20/1992 | EP0401369A4 Method for preparative expression of genes in a cell-free system of conjugated transcription/translation |
| 05/20/1992 | EP0229110B1 Solubilization and oxidation of somatotropin from transformed microorganisms |
| 05/20/1992 | EP0209539B1 Homogeneous erythropoietin |
| 05/20/1992 | EP0131627B1 Specific cea-family antigens, antibodies specific thereto and their methods of use |
| 05/20/1992 | CA2096542A1 Protein staining compositions and methods |
| 05/19/1992 | US5115102 Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices |
| 05/19/1992 | US5114962 New amino acid esters, a process for their preparation, medicaments containing them, and the use thereof |
| 05/19/1992 | US5114927 Hypotensive agents and inhibiting renin |
| 05/19/1992 | US5114926 Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses |
| 05/19/1992 | US5114922 Animal extracts from leeches |
| 05/19/1992 | US5114713 P. falciparum cs-peptides as universal t-cell epitope |
| 05/19/1992 | US5114589 Type-XLL cross-axis synchronous flow-through coil planet centrifuge for separation of biopolymers |
| 05/19/1992 | US5114555 Separation of proteins with membranes in a multicompartment apparatus |
| 05/16/1992 | CA2048078A1 Chemical modification of antibodies for creation of immunoconjugates |
| 05/15/1992 | WO1992008482A1 Compositions for reducing oxidative injury |
| 05/15/1992 | CA2096333A1 Compositions for reducing oxidative injury |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007868A1 A method for isolating and purifying peptides and proteins |